ORAGENICS, INC. Income Taxes Receivable, Current
ORAGENICS, INC. (OGEN) had Income Taxes Receivable, Current of $0 as of 2011-06-30, per its 10-Q filed 2011-08-05.
Discontinued › Notes › Nontrade Receivables
us-gaap:IncomeTaxesReceivable · last filed 2012-04-16
- 2011-06-30: Income Taxes Receivable, Current $0.00.
- 2010-12-31: Income Taxes Receivable, Current $362.22K.
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2011-06-30 | $0.00 10-Q · filed 2011-08-05 |
| 2010-12-31 | $362.22K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |